<DOC>
	<DOCNO>NCT01248065</DOCNO>
	<brief_summary>The purpose study find take vitamin D addition asthma controller medication help prevent worsen asthma symptom asthma attack .</brief_summary>
	<brief_title>Study Effect Vitamin D Add-on Therapy Corticosteroids Asthma</brief_title>
	<detailed_description>This randomize , double-blind parallel group trial enroll individual vitamin D insufficiency asthma persistent symptom despite low-dose inhaled corticosteroid . Participants low-dose inhaled corticosteroid randomize add-on therapy either placebo high-dose vitamin D 28-week period . During inhaled corticosteroid-stable phase , participant remain low-dose inhaled corticosteroid . During inhaled corticosteroid-taper phase , participant taper inhale corticosteroid 50 % two time-points post-randomization . The investigator determine addition vitamin D reduce likelihood treatment failure compare placebo inhale corticosteroid-stable inhaled corticosteroid-taper phase study . Given high prevalence vitamin D insufficiency asthma , trial high potential impact daily asthma management .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Men woman 18 year age old Physiciandiagnosed asthma least previous 12 month Asthma confirm : ( ) βagonist reversibility force expiratory volume 1 second ( FEV1 ) ≥12 % follow 180 mcg ( 4 puff ) levalbuterol visit 1 OR ( b ) methacholine provocative concentration cause 20 % fall FEV1 ( PC20 ) ≤ 8 mg/ml receive inhale corticosteroid ≤ 16 mg/ml receive inhale corticosteroid visit 2 . Source documentation PC20 AsthmaNet methacholine challenge complete within 6 month visit 2 accept . Stable asthma controller therapy ( inhaled corticosteroid leukotriene modifier ) dose past 2 week FEV1 ≥ 50 % predict visit 1 Vitamin D level le 30 ng/ml visit 0 Experienced one treatment failure VIDA runin oral corticosteroid ( OCS ) response period previous enrollment For woman childbearing potential : pregnant , nonlactating , agree practice adequate birth control method duration study Taking vitamin D supplement contain &gt; 1000 IU/day vitamin D Taking &gt; 2500 mg/day calcium supplement Chronic oral corticosteroid therapy Chronic inhale corticosteroid therapy &gt; 1,000 mcg fluticasone daily equivalent History physiciandiagnosed nephrolithiasis Use concomitant medication alter vitamin D metabolism phenytoin , phenobarbital , cardiac glycoside ; absorption orlistat , cholestyramine , colestipol ; interfere study endpoint Impaired renal function ( GFR &lt; 30 ml/min ) Asthma exacerbation within past 4 week require systemic corticosteroid Respiratory tract infection within past 4 week Chronic disease ( asthma ) History cigarette smoking within past 1 year &gt; 10 pack year total Serum calcium great 10.2 mg/dl entry Urine calcium/creatinine ratio great 0.37 ( urinary Ca Creat mg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Treatment failure</keyword>
</DOC>